800-543-0660 Phone Icon Location Icon

"The practice has a great reputation around Boston. Everyone I know that has gone in has been happy with their results."

Chris Wagner
Boston Bruins Player
						https://www.hairdr.com/wp-content/uploads/2018/12/rob-1.png					

Dr. Mary Lopresti Curriculum Vitae

PERSONAL INFORMATION

EDUCATION
Undergraduate:
– University of Connecticut, 2002
Medical School:
– University of New England College of Osteopathic Medicine, D.O., 2008

POSTGRADUATE TRAINING
Residency:
– University of Massachusetts Medical School, Worcester, Massachusetts 2011
Fellowship:
– University of Massachusetts Medical School, Worcester, Massachusetts 2014

PROFESSIONAL LICENSES & BOARD CERTIFICATION
American Board of Hematology
– Board Certified 2016

American Board of Oncology
– Board Certified 2014

American Board of Internal Medicine
– Board Certified 2011

State Licenses:
– Massachusetts
– Rhode Island

HOSPITAL APPOINTMENTS
– Rhode Island Hospital, Providence, Rhode Island
– The Miriam Hospital, Providence, Rhode Island

PROFESSIONAL ORGANIZATIONS
– NRG
– Massachusetts Medical Society
– American Society of Hematology
– American Society of Clinical Oncology

PRESENTATIONS
ASCO Quality Symposium, September 24-25, 2021
– An assessment of fertility preservation practices among oncology providers

ASCO Annual Meeting, 2021
– Survey of caregiver needs after their loved ones completed cancer treatment

Accepted for Oral Presentation, April 11, 2021
– Final phase 1 study results from the dose-escalation and dose-expansion cohorts

Am Soc Breast Surg Annual Meeting 2020
– Effect of Weekly Caboplatin and Paclitaxel with Trastuzumab and Pertuzumab (wPCbTP) on Nodal Disease and Surgical Option in HER2-positive Breast Cancer

National Consortium of Breast Centers Annual Meeting, March 2019
– The Impact of Recurrence Score versus Sentinel Lymph Node Biopsy on Treatment Decisions in Early Breast Cancer

USCAP, 2019
– Performance and Utility of Breast Cancer Oncotype Dx Testing on Core Needle Biopsies

San Antonio Breast Cancer Symposium, December 2019
– A Brown University Oncology (BrUOG) study

American Society of Breast Surgeons Annual Meeting, 2019
– Characterizing what causes the thermometer to rise in patients with newly diagnosed breast cancer attending a multidisciplinary clinic

National Consortium of Breast Centers Annual Meeting, 2019
– The Impact of Recurrence Score versus Sentinel Lymph Node Biopsy on Treatment Decisions in Early Breast Cancer

San Antonio Breast Cancer Symposium, 2019
– Choosing Wisely: In an era of genomic medicine, what role does nodal information play in decisions regarding adjuvant chemotherapy for early-stage, hormone reptor-positive breast cancer?

Submitted to American Society of Clinical Oncology Annual Meeting, 2019
– Brown University Oncology Group (BrUOG) 354: A phase ​​II randomized trial of nivolumab +/-ipilimumab for ovarian and extra-renal clear cell carcinomas

American Society of Clinical Oncology Annual Meeting, 2019
– After cancer, what’s more important: the survivorship care plan or the survivorship care visit?

Hematology Oncology Pharmacy Association Annual Conference in Atlanta, 2016
– “Pertuzumab-associated Diarrhea in Her-2 Positive Breast Cancer Patients: A Comparison of Trials to Actual Practice.”

ASTRO (American Society for Radiation Oncology) Conference, 2014
– “Lack of breast cancer screening in women at high risk after supra diaphragmatic irradiation for pediatric malignancies.”

San Antonio Breast Cancer Symposium, 2013
– “Breast cancer risk reduction in high risk women identified at the time of screening mammography. Integrating data from an established high-risk clinic.”

Massachusetts Medical Society Eighth Annual Poster Symposium, 2013
– “Identifying women at high risk for invasive breast cancer at the time of screening mammography.”

American Society of Clinical Oncology (ASCO) Breast Symposium, 2013
– “Identifying women at high risk for invasive breast cancer at the time of screening mammography.”

UMass Memorial Medical Center, 2011
– “Novel measurements of mammary stem cells in human umbilical cord blood as prospective predictors of breast cancer susceptibility in later life.”

INVITED PRESENTATIONS
Local:

Young Fight Strong Program & Avenues for Research
– Breast Cancer Translational Research and Disease Group
– Alpert Medical School of Brown University
– Rhode Island Hospital, 2021

San Antonio Breast Cancer Symposium (SABCS) Update 2019
– Department of Hematology Oncology Grand Rounds
– Alpert Medical School of Brown University
– Rhode Island Hospital, January 2020

San Antonio Breast Cancer Symposium (SABCS) Update 2018
– Department of Hematology Oncology Grand Rounds
– Alpert Medical School of Brown University
– Rhode Island Hospital, January 2019

San Antonio Breast Cancer Symposium (SABCS) Update 2017
– Department of Hematology Oncology Grand Rounds
– Alpert Medical School of Brown University
– Rhode Island Hospital, January 2018

The Chase: Lifespan’s Young Women’s Program & Research
– Avenues of Healing, October 2017

SABCS update 2016
– Department of Hematology Oncology Grand Rounds
– Alpert Medical School of Brown University, January 2017

The Evolving Blueprint in Breast Cancer
– Department of Medicine Grand Rounds
– Alpert Medical School of Brown University, September 2017

The Changing Landscapes in Breast Cancer
– Department of Hematology Oncology Grand Rounds
– Alpert Medical School of Brown University, June 2016

San Antonio Breast Cancer Symposium Update 2015
– Department of Hematology Oncology Grand Rounds
– Alpert Medical School of Brown University, January 2016

San Antonio Breast Cancer Symposium Update 2014
– Department of Hematology Oncology Grand Rounds
– Alpert Medical School of Brown University, January 2015

Regional:

Precision in Breast Cancer & Caring for the Survivor – UNE CME Symposium
– University of New England College of Osteopathic Medicine Medical School, Biddeford, ME, October 2018

The Changing Landscapes in Breast Cancer
– Department of Hematology Oncology Grand Rounds, University of Massachusetts Medical School, May 2016

To take a risk or not to take a risk? Prevention & Chemoprophylaxis
– Department of Hematology Oncology Grand Rounds, University of Massachusetts Medical School, April 2014

Breast Cancer Panel Discussion: Prevention and screening
– Worcester Polytechnic Institute, Worcester, MA; October 2013

Prevention and screening
– Bridge Summit- American Chinese Academy of Medicine, Boston Children’s Hospital; October 2013

Identifying women at high risk for breast cancer
– Pink Lighting the Way Breast Cancer Awareness Event, University of Massachusetts Medical School; October 2013

Breast cancer survivorship- Tending to life after chemotherapy
– Department of Hematology Oncology Grand Rounds, University of Massachusetts Medical School, August 2013

Case Presentation: Big Red’s Race to the Finish
– University of Massachusetts Medical School; May 2011.

Assessing Chronic Pain in Opioid-Dependent Population
– New England Dean’s Fellowship Award Presentation. University of New England College of Osteopathic Medicine Medical School, 2005

CA90902: Stem Cells and Perinatal Factors for Breast Cancer Risk
– UMass Memorial Medical Center; Worcester, MA; April 2010

A Nagging Pain to Priority Pain Relief, Evaluating Pain Management in Hospitalized Patients at UMMHC
– UMass Memorial Medical Center; Worcester, MA; April 2009

Assessing Chronic Pain in Opioid-Dependent Population
– University of New England College of Osteopathic Medicine Medical School; Biddeford, ME; 2005

MEDIA COVERAGE – PODCAST
ASCO Daily News Podcast, April 2019
Preserving a Future Family: Dr. Mary Lopresti on Oncofertility